Kimberly Manhard's Net Worth
$4.88 Million
Estimate Recalculated Nov 7, 2024 12:03PM EST
Who is Kimberly Manhard?
Kimberly Manhard has an estimated net worth of $4.88 Million. This is based on reported shares across multiple companies, which include Inhibrx, Inc., HERON THERAPEUTICS, INC. /DE/, Ardea Biosciences, Inc./DE, and Inhibrx Biosciences, Inc..
SEC CIK
Kimberly Manhard's CIK is 0001202094
Past Insider Trading and Trends
2010 was Kimberly Manhard's most active year for acquiring shares with 14 total transactions. Kimberly Manhard's most active month to acquire stocks was the month of November. 2010 was Kimberly Manhard's most active year for disposing of shares, totalling 26 transactions. Kimberly Manhard's most active month to dispose stocks was the month of May. 2019 saw Kimberly Manhard paying a total of $332,436.65 for 145,109 shares, this is the most they've acquired in one year. In 2012 Kimberly Manhard cashed out on 317,029 shares for a total of $5,266,270.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inhibrx, Inc. (INBX) Snapshot price: $15.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $1.81
EVP, Drug Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.37% | 4.4K |
$2.88 | -$4,080.96 | 28.33K |
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +29.54% | 5.46K |
$3.22 | -$6,378.04 | 23.93K |
Oct 31 - Jan 13
| |||
Form 4
| +25.91% | 3.8K |
$3.76 | -$7,565.12 | 18.48K |
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
| +34.97% | 3.8K |
$3.01 | -$6,056.12 | 14.67K |
Jul 13
| |||
Form 4
|
—
|
0
|
$4.30 | -$1,375.26 | 10.87K |
Scheduled
|
Apr 29 - May 3
| ||
Form 4
| +53.78% | 3.8K |
$6.07 | -$12,212.84 | 10.87K |
Apr 13
| |||
Form 4
| +116.34% | 3.8K |
$8.30 | -$16,699.60 | 7.07K |
Jan 13
| |||
Form 4
| +33.33% | 817 |
$10.55 | -$4,568.15 | 3.27K |
Oct 13
| |||
Form 4
| +50.00% | 817 |
$13.48 | -$5,836.84 | 2.45K |
Jul 13
| |||
Form 4
|
—
|
0
|
$15.78 | -$5,759.43 | 1.63K |
Scheduled
|
Apr 30 - May 3
| ||
Form 4
| +100.00% | 817 |
$16.66 | -$7,213.78 | 1.63K |
Apr 13
| |||
Form 4
|
∞
| 817 |
$18.16 | -$7,863.28 | 817 |
Jan 13
| |||
Form 4
|
—
|
0
|
$16.50 | -$70,000.00 |
0
|
Scheduled
|
Dec 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
$13.05 | -$2,139.63 |
0
|
Scheduled
|
Apr 30 - May 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
$19.50 | -$312,000.00 |
0
|
Scheduled
|
Nov 29
| ||
Form 4
|
—
|
0
|
$18.65 | -$481.42 |
0
|
Scheduled
|
Apr 30 - May 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
$27.11 | -$3,468.53 |
0
|
Scheduled
|
Oct 31 - Nov 2
| ||
Form 4
|
—
|
0
|
$22.54 | -$114,433.20 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$25.27 | -$147,178.66 |
0
|
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$21.50 | -$306,000.00 |
0
|
Scheduled
|
Mar 19
| ||
Form 4
|
—
|
0
|
$16.50 | -$53,088.00 |
0
|
Scheduled
|
Jan 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
$12.16 | -$136,619.96 |
0
|
Scheduled
|
Apr 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
$15.97 | -$188,010.96 |
0
|
Jun 1 - Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ardea Biosciences, Inc./DE No price found
SVP, Regulatory & Dev Ops
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.20K |
$32.00 | -$326,400.00 |
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
$22.08 | -$253,490.77 | 10.2K |
Jun 19
| |||
Form 4
|
—
|
0
|
$17.90 | -$139,929.50 | 9.97K |
Scheduled
|
May 29
| ||
Form 4
|
—
|
0
|
$17.86 | -$139,577.50 | 9.73K |
Scheduled
|
Apr 30
| ||
Form 4
|
—
|
0
|
$13.27 | -$93,772.00 | 9.73K |
Scheduled
|
Mar 28
| ||
Form 4
|
—
|
0
|
$12.44 | -$85,470.50 | 9.73K |
Scheduled
|
Feb 28
| ||
Form 4
|
—
|
0
|
$10.96 | -$70,530.00 | 9.73K |
Scheduled
|
Jan 30
| ||
Form 4
|
—
|
0
|
$10.43 | -$65,361.50 | 9.73K |
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
$10.79 | -$68,857.00 | 9.73K |
Scheduled
|
Nov 28
| ||
Form 4
|
—
|
0
|
$12.59 | -$86,873.50 | 9.39K |
Scheduled
|
Oct 28
| ||
Form 4
|
—
|
0
|
$10.09 | -$61,923.00 | 9.39K |
Scheduled
|
Sep 28
| ||
Form 4
|
—
|
0
|
$9.52 | -$56,133.50 | 9.39K |
Scheduled
|
Aug 29
| ||
Form 4
|
—
|
0
|
$13.73 | -$98,313.00 | 9.39K |
Scheduled
|
Jul 28
| ||
Form 4
|
—
|
0
|
$14.64 | -$107,374.50 | 9.39K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
$14.36 | -$104,672.50 | 9.39K |
Scheduled
|
May 31
| ||
Form 4
|
—
|
0
|
$15.85 | -$119,522.00 | 9.04K |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
$15.83 | -$119,323.50 | 9.04K |
Scheduled
|
Mar 28
| ||
Form 4
|
—
|
0
|
$15.20 | -$112,983.00 | 9.04K |
Scheduled
|
Feb 28
| ||
Form 4
|
—
|
0
|
$15.64 | -$117,423.00 | 9.04K |
Scheduled
|
Jan 28
| ||
Form 4
| +123.64% | 5K |
$15.26 | -$94,075.50 | 9.04K |
Scheduled
|
Dec 28 - Dec 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
$13.07 | -$91,718.50 | 4.04K |
Scheduled
|
Nov 29
| ||
Form 4
|
—
|
0
|
$12.47 | -$85,644.00 | 3.7K |
Scheduled
|
Oct 28
| ||
Form 4
|
—
|
0
|
$13.47 | -$95,639.00 | 3.7K |
Scheduled
|
Sep 28
| ||
Form 4
| -51.75% | -3.97K |
$11.95 | -$159,835.79 | 3.7K |
Scheduled
|
Aug 30
| ||
Form 4
|
—
|
0
|
$11.67 | -$38,849.75 | 7.67K |
Scheduled
|
Jul 28
| ||
Form 4
|
—
|
0
|
$12.91 | -$45,058.75 | 7.67K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
$14.43 | -$52,672.99 | 7.67K |
Scheduled
|
May 28
| ||
Form 4
|
—
|
0
|
$14.53 | -$53,162.25 | 7.33K |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
$11.31 | -$37,040.00 | 7.33K |
Scheduled
|
Mar 29
| ||
Form 4
|
—
|
0
|
$9.09 | -$25,958.50 | 7.33K |
Scheduled
|
Feb 26
| ||
Form 4
|
—
|
0
|
$9.22 | -$26,600.00 | 7.33K |
Scheduled
|
Jan 28
| ||
Form 4
|
—
|
0
|
$9.20 | -$26,474.75 | 7.33K |
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
$9.17 | -$26,347.00 | 7.33K |
Scheduled
|
Nov 27
| ||
Form 4
|
—
|
0
|
$9.05 | -$25,758.00 | 6.41K |
Scheduled
|
Oct 28
| ||
Form 4
|
—
|
0
|
$11.50 | -$37,992.50 | 6.41K |
Scheduled
|
Sep 28
| ||
Form 4
|
—
|
0
|
$11.15 | -$36,232.25 | 6.41K |
Scheduled
|
Aug 28
| ||
Form 4
| +136.38% | 3.7K |
$9.48 | -$223,167.24 | 6.41K |
May 19
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inhibrx Biosciences, Inc. (INBX) Snapshot price: $15.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10K |
$13.98 | $139,800.00 | 10K |
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||